Biogen’s Leqembi to drive Alzheimer’s market to $14B in 2030
filadendron/E+ via Getty Images Driven by new therapies from Biogen (Nasdaq: BIIB) / Esay (OTCPK: ESALF) and Eli Lilly (New York Stock Exchange: LLY), the Alzheimer's disease market in eight major countries will reach $13.7 billion in…